The U.S. Food and Drug Administration has granted Fast Track Designation to a new drug combination for metastatic colorectal cancer, following encouraging results from a clinical trial led in part...

For more than 35 years, University of Oklahoma Health Campus researchers have played a key role in the Strong Heart Study, a landmark project that has uncovered critical insights into...

Abdul Rafeh Naqash, M.D., associate professor at the University of Oklahoma College of Medicine and an oncologist at OU Health Stephenson Cancer Center, has been named a fellow of the American...